Showing results (171-180 of 232) with videos related to
Sort By:
Pageof 24
Parkinsonism & Related Disorders|January 2, 2022
Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's diseaseJohannes C Rothlind, Michele K York, Ping Luo, et al.Acta Biomaterialia|March 20, 2026
Biopreservation of a tissue engineered nigrostriatal pathway for tract reconstruction in Parkinson's diseaseDimple Chouhan, Kevin D Browne, Wisberty J Gordián Vélez, et al.Science (New York, N.Y.)|June 8, 2013
A major asymmetric dust trap in a transition diskNienke van der Marel, Ewine F van Dishoeck, Simon Bruderer, et al.The Lancet. Neurology|November 14, 2009
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteriaDennis W Dickson, Heiko Braak, John E Duda, et al.Parkinsonism & Related Disorders|March 1, 2016
Olfactory impairment predicts cognitive decline in early Parkinson's diseaseMichelle E Fullard, Baochan Tran, Sharon X Xie, et al.The American Journal of Pathology|November 14, 2000
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathiesJ E Duda, B I Giasson, Q Chen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's diseaseDaniel Weintraub, Andrew B Newberg, Mark S Cary, et al.Neurology|September 1, 2019
Excessive daytime sleepiness and topographic expansion of Lewy pathologyRobert D Abbott, G Webster Ross, John E Duda, et al.Journal of Parkinson'S Disease|January 2, 2021
Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's DiseaseJulia Gallagher, Jacqueline Rick, Sharon X Xie, et al.Neurology|August 4, 2010
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseD Weintraub, S Mavandadi, E Mamikonyan, et al.Pageof 24